UK approves first Alzheimer drug for early use
The Medicines and Healthcare products Regulatory Agency (MHRA) approved on Thursday, a product license for the medicine lecanemab for use in the early stages of Alzheimer’s, after proving that it slow the progression of disease by 27 percent.
The me…